Terms: = Colorectal cancer AND CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1
23 results:
1. Utility of cyp2d6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
Trilla-Fuertes L; Gámez-Pozo A; Nogué M; Busquier I; Arias F; López-Campos F; Fernández-Montes A; Ruiz A; Velázquez C; Martín-Bravo C; Pérez-Ruiz E; Asensio E; Hernández-Yagüe X; Rodrigues A; Ghanem I; López-Vacas R; Hafez A; Arias P; Dapía I; Solís M; Dittmann A; Ramos R; Llorens C; Maurel J; Campos-Barros Á; Fresno Vara JÁ; Feliu J
Cancer; 2023 Aug; 129(16):2581-2592. PubMed ID: 37096763
[TBL] [Abstract] [Full Text] [Related]
2. Genetic Polymorphisms of Cytochromes P450 in Finno-Permic Populations of Russia.
Dzhaubermezov M; Ekomasova N; Mustafin R; Gabidullina L; Galimova Y; Nurgalieva A; Valova Y; Prokofyeva D; Khusnutdinova E
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553620
[TBL] [Abstract] [Full Text] [Related]
3. Development of Caco-2 cells expressing four CYPs via a mammalian artificial chromosome.
Ohta Y; Kazuki K; Abe S; Oshimura M; Kobayashi K; Kazuki Y
BMC Biotechnol; 2020 Aug; 20(1):44. PubMed ID: 32819341
[TBL] [Abstract] [Full Text] [Related]
4. Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations.
Rapoport BL; Aapro M; Chasen MR; Jordan K; Navari RM; Schnadig I; Schwartzberg L
Drug Des Devel Ther; 2017; 11():2621-2629. PubMed ID: 28919712
[TBL] [Abstract] [Full Text] [Related]
5. Pharmacogenetics in cancer therapy - 8 years of experience at the Institute for Oncology and Radiology of Serbia.
Cavic M; Krivokuca A; Boljevic I; Brotto K; Jovanovic K; Tanic M; Filipovic L; Zec M; Malisic E; Jankovic R; Radulovic S
J BUON; 2016; 21(5):1287-1295. PubMed ID: 27837635
[TBL] [Abstract] [Full Text] [Related]
6. Breath tests to phenotype drug disposition in oncology.
Opdam FL; Modak AS; Gelderblom H; Guchelaar HJ
Clin Pharmacokinet; 2013 Nov; 52(11):919-26. PubMed ID: 23868281
[TBL] [Abstract] [Full Text] [Related]
7. cyp2d6 metabolism and patient outcome in the Austrian Breast and colorectal cancer Study Group trial (ABCSG) 8.
Goetz MP; Suman VJ; Hoskin TL; Gnant M; Filipits M; Safgren SL; Kuffel M; Jakesz R; Rudas M; Greil R; Dietze O; Lang A; Offner F; Reynolds CA; Weinshilboum RM; Ames MM; Ingle JN
Clin Cancer Res; 2013 Jan; 19(2):500-7. PubMed ID: 23213055
[TBL] [Abstract] [Full Text] [Related]
8. Pharmacogenomic contribution to drug response.
Watson RG; McLeod HL
Cancer J; 2011; 17(2):80-8. PubMed ID: 21427551
[TBL] [Abstract] [Full Text] [Related]
9. Germline genetic variation, cancer outcome, and pharmacogenetics.
Coate L; Cuffe S; Horgan A; Hung RJ; Christiani D; Liu G
J Clin Oncol; 2010 Sep; 28(26):4029-37. PubMed ID: 20679599
[TBL] [Abstract] [Full Text] [Related]
10. Adjuvant endocrine therapy of premenopausal women with early breast cancer: an overview.
Hubalek M; Brantner C; Marth C
Wien Med Wochenschr; 2010 Apr; 160(7-8):167-73. PubMed ID: 20473727
[TBL] [Abstract] [Full Text] [Related]
11. Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk.
Northwood EL; Elliott F; Forman D; Barrett JH; Wilkie MJ; Carey FA; Steele RJ; Wolf R; Bishop T; Smith G
Pharmacogenet Genomics; 2010 May; 20(5):315-26. PubMed ID: 20375710
[TBL] [Abstract] [Full Text] [Related]
12. Pharmacogenetics of solid tumors: directed therapy in breast, lung, and colorectal cancer: a paper from the 2008 william beaumont hospital symposium on molecular pathology.
Snozek CL; O'Kane DJ; Algeciras-Schimnich A
J Mol Diagn; 2009 Sep; 11(5):381-9. PubMed ID: 19644023
[TBL] [Abstract] [Full Text] [Related]
13. Genetic polymorphisms of cyp2d6 oxidation in patients with inflammatory bowel disease.
Trzcinski R; Skretkowicz J; Dziki A; Rychlik-Sych M; Baranska M
Dig Dis Sci; 2010 Apr; 55(4):1037-43. PubMed ID: 19437119
[TBL] [Abstract] [Full Text] [Related]
14. Pharmacogenomics of tamoxifen and irinotecan therapies.
Algeciras-Schimnich A; O'Kane DJ; Snozek CL
Clin Lab Med; 2008 Dec; 28(4):553-67. PubMed ID: 19059062
[TBL] [Abstract] [Full Text] [Related]
15. A prospective study of isolated human hepatocyte function following liver resection for colorectal liver metastases: the effects of prior exposure to chemotherapy.
Hewes JC; Riddy D; Morris RW; Woodrooffe AJ; Davidson BR; Fuller B
J Hepatol; 2006 Aug; 45(2):263-70. PubMed ID: 16635536
[TBL] [Abstract] [Full Text] [Related]
16. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.
Landi S; Gemignani F; Moreno V; Gioia-Patricola L; Chabrier A; Guino E; Navarro M; de Oca J; Capellà G; Canzian F;
Pharmacogenet Genomics; 2005 Aug; 15(8):535-46. PubMed ID: 16006997
[TBL] [Abstract] [Full Text] [Related]
17. Cytochrome P450 gene polymorphism and cancer.
Agundez JA
Curr Drug Metab; 2004 Jun; 5(3):211-24. PubMed ID: 15180491
[TBL] [Abstract] [Full Text] [Related]
18. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
[TBL] [Abstract] [Full Text] [Related]
19. Phenotype of cytochrome P450 cyp2d6 in patients with familial adenomatous polyposis.
Slanar O; Perlík F; Jirásek V
Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):145-7. PubMed ID: 11523314
[TBL] [Abstract] [Full Text] [Related]
20. Host determinants of DNA alkylation and DNA repair activity in human colorectal tissue: O(6)-methylguanine levels are associated with GSTT1 genotype and O(6)-alkylguanine-DNA alkyltransferase activity with cyp2d6 genotype.
Povey AC; Hall CN; Badawi AF; Cooper DP; Guppy MJ; Jackson PE; O'Connor PJ; Margison GP
Mutat Res; 2001 Aug; 495(1-2):103-15. PubMed ID: 11448648
[TBL] [Abstract] [Full Text] [Related]
[Next]
